How does the rate of steroid tapering affect remission and relapse rates in ANCA glomerulonephritis?

Zenodo (CERN European Organization for Nuclear Research) 2026 Open access

Read full text
Authors: Tripdatabase
DOI: 10.5281/zenodo.18548627
Cited by: 0

Abstract

Optimal glucocorticoid tapering in ANCA-glomerulonephritis remains under investigation, with evidence suggesting that a structured reduction over several months is key to balancing remission and relapse risk.

Fields of Study & Subjects

Vasculitis and related conditions Renal Diseases and Glomerulopathies Systemic Lupus Erythematosus Research

Publication details

Journal / source
Zenodo (CERN European Organization for Nuclear Research)
Publication date
9 February 2026